Agios Pharm (AGIO) — Cash Flow Reinvestment Rate

Latest as of June 2016: 0.26x

Agios Pharm (AGIO) has a Cash Flow Reinvestment Rate of 0.26x as of June 2016, reinvesting $41.21 Million (capex $2.73 Million plus investments $38.47 Million) from operating cash flow of $157.82 Million. Check Agios Pharm cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.26x
(Capex + Investments) / Operating CF

Total Reinvested

$41.21 Million
Capex + Investments

Operating Cash Flow

$157.82 Million
USD

Capital Expenditures

$2.73 Million
USD

Agios Pharm Cash Flow Reinvestment Rate (2016–2016)

Historical reinvestment intensity for Agios Pharm across 1 annual periods. Explore investment intensity of Agios Pharm to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for Agios Pharm (2016–2016)

Year-by-year capital reinvestment analysis for Agios Pharm. For live market cap and broader valuation context, see Agios Pharm market capitalisation.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2016 3.10x $119.35 Million $38.56 Million $9.91 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow